Search Within

Henry Stuart Walch

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (36)
  3. Conference Paper (1)
  4. Correspondence (1)
Groups
  1. Human Oncology and Pathogenesis Program (82)
  2. GSK Faculty (81)
  3. Epidemiology and Biostatistics (78)
  4. Department of Medicine (77)
  5. Solid Tumor Oncology Division (77)
  6. Computational Oncology Service (71)

More Groups

People
  1. Nikolaus Schultz (71)
  2. Walid Chatila (44)
  3. Rona Yaeger (26)
  4. Andrea Cercek Hanjis (25)
  5. Michael Berger (24)
  6. David Solit (23)

More People

Years
  1. 2025 (9)
  2. 2024 (18)
  3. 2023 (22)
  4. 2022 (18)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Clinical Cancer Research (11)
  3. Cancer Research (6)
  4. Annals of Surgical Oncology (5)
  5. JNCI: Journal of the National Cancer Institute (4)
  6. Neuro-Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. American Association for Cancer Research (17)
  3. Oxford University Press (10)
  4. Elsevier Inc. (6)
  5. Nature Publishing Group (6)
  6. Springer (5)

More Publishers

Results (82)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent germline BRCA1/2 and mismatch repair mutations in young-onset pancreatic and colorectal cancer: The importance of comprehensive germline and somatic characterization to inform therapeutic options
    Journal Article

    Ozer, M.; Ranganathan, M.; Lecomte, N.; Schvartzman, J. M.; Walch, H. S.; Chatila, W. K.; Hong, J.; Carlo, M. I.; Walsh, M. F.; Sheehan, M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • The role of the TP53 pathway in predicting response to neoadjuvant therapy in esophageal adenocarcinoma
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; De La Torre, S.; Janjigian, Y. Y.; Maron, S. B.; Ku, G. Y.; Tang, L. H.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Transcriptomic profiling to identify subsets of immune hot locally advanced rectal adenocarcinomas with favorable outcomes after neoadjuvant treatment
    Meeting Abstract

    Sanchez Vega, F.; Chatila, W. K.; Kim, J. K.; Walch, H. S.; Marco, M.; Chen, C. T.; Wu, F.; Khalil, D.; Ganesh, K.; Qu, X.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Nakauchi, M.; Walch, H. S.; Chatila, W. K.; Tran, T.; Vos, E. L.; Sihag, S.; Tang, L. H.; Coit, D. G.; Stadler, Z. K.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years
    Journal Article

    Narayan, R. R.; Aveson, V. G.; Chou, J. F.; Walch, H. S.; Sanchez-Vega, F.; Dos Santos Fernandes, G.; Balachandran, V. P.; D'Angelica, M. I.; Drebin, J. A.; Jarnagin, W. R.; more...
    Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Defining and targeting esophagogastric cancer genomic subsets with patient-derived xenografts
    Journal Article

    Moy, R. H.; Walch, H. S.; Mattar, M.; Chatila, W. K.; Molena, D.; Strong, V. E.; Tang, L. H.; Maron, S. B.; Coit, D. G.; Jones, D. R.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • A comprehensive comparison of early-onset and average-onset colorectal cancers
    Journal Article

    Cercek, A.; Chatila, W. K.; Yaeger, R.; Walch, H.; Dos Santos Fernandes, G.; Krishnan, A.; Palmaira, L.; Maio, A.; Kemel, Y.; Srinivasan, P.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genetic determinants of outcome in intrahepatic cholangiocarcinoma
    Journal Article

    Boerner, T.; Drill, E.; Pak, L. M.; Nguyen, B.; Sigel, C. S.; Doussot, A.; Shin, P.; Goldman, D. A.; Gonen, M.; Allen, P. J.; more...
    Hepatology (2021)

    Fulltext@MSK | Save